SYS6002-001, CTR20222932: An open-label, single-arm, multicenter phase I clinical trial evaluating the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of SYS6002 in patients with advanced solid tumors |
|
|
| Recruiting | 1 | 380 | China | CRB-701 - CSPC Pharma, Corbus Pharma | CSPC Pharmaceutical Group Jushi Biopharmaceutical Co., Ltd | Advanced solid tumors | | | | |
